Lilly’s Olomorasib Earns FDA Breakthrough Therapy Designation
Indianapolis, August 3, 2026 Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted...
AI medical device
Advertisement
Fresenius Kabi Gains FDA Approval for Rituximab Biosimilar
Bad Homburg, Germany, August 3, 2026 Fresenius Kabi, an operating company of Fresenius, announced that the U.S. Food and...
Invenio Imaging Completes Enrollment in AI Lung Cancer Study
San Jose, California, August 3, 2026 Invenio Imaging announced the completion of patient enrollment in the ON-SITE pivotal study,...
PROCEPT Launches HYDROS AI Robotic System for BPH Care
SAN JOSE, Calif., March 12, 2026 PROCEPT BioRobotics has announced the international launch of its HYDROS® Robotic System, a...
Advertisement
